Purchase Order 75N91020P00159
Award Date 1/16/20
Potential Completion Date 1/15/21
Potential Value $21K
Federal Agency
Ultimate Awardee
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Bethesda, MD 20892, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The National Cancer Institute issued a delivery order to Becton, Dickinson And Company on December 23, 2015, with a ceiling value of $18,559.35 and an ultimate completion date of February 19, 2017. Place of performance is Bethesda, MD 20892. The order is priced on a firm fixed-price basis and was issued without a set-aside. Becton, Dickinson And Company, through its BD Biosciences division, supplies flow cytometry instruments, reagents, and consumables essential to biomedical research and...
- <p>The National Cancer Institute awarded a purchase order to Becton, Dickinson and Company for $22,791.36 on December 16, 2019, with an ultimate completion date of December 16, 2019. Work is performed in Bethesda, Maryland. The order procures flow cytometry detector options to support the National Cancer Institute's laboratory and research operations. Pricing is firm fixed price with no small business set-aside applied.</p>
- The National Cancer Institute issued a delivery order to Becton, Dickinson and Company on April 26, 2018, with a ceiling value of $23,302.20 for a BD Biosciences maintenance agreement. Place of performance is San Jose, CA 95131. The order is effective through May 31, 2019. The delivery order covers maintenance services for BD Biosciences flow cytometry and laboratory instrumentation, issued under the GSA Scientific Equipment and Services Schedule (FSS-66) on a firm fixed price basis.
- The National Cancer Institute issued a delivery order to Becton, Dickinson and Company on November 6, 2019, with a ceiling value of $11,668.20, for a maintenance agreement under the GSA Schedule for Scientific Equipment and Services (FSS-66). Place of performance is San Jose, CA 95131. The order completed on November 30, 2020. Becton, Dickinson and Company, a large for-profit medical technology manufacturer operating through its BDB Division as BD Biosciences, supplies flow cytometry...
- The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a firm fixed-price purchase order to Becton, Dickinson and Company (BD), a global medical technology company, for preventive maintenance, emergency service, support, and coverage for four government-owned BD Biosciences flow cytometry instruments. The one-year contract with four option years, valued at $148,833.48, provides for semi-annual preventive maintenance, on-site emergency repair...
- The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a $20,809.08 firm fixed price purchase order to Becton, Dickinson and Company BD Biosciences, Systems and Reagents Division for a service agreement. As the prime contractor, Becton, Dickinson and Company BD Biosciences will provide unspecified services to the National Cancer Institute, which conducts and supports research across the nation with the goal of discovering prevention and...
- This is a purchase order contract awarded by the Department of Health and Human Services National Institutes of Health National Cancer Institute to Becton, Dickinson And Company (BD) for a maintenance agreement. The contract has a firm fixed price of $17,387.91 and a completion date of July 26, 2024. BD is a global medical technology company that provides instruments, reagents, and services supporting biomedical research and clinical applications, particularly through flow cytometry, cell...
- The National Heart Lung and Blood Institute awarded a purchase order to Becton, Dickinson and Company (BD Biosciences) for $29,795.40 on January 23, 2019, for a maintenance agreement with an ultimate completion date of January 31, 2020. Work is performed at Bethesda, Maryland. The order is firm fixed price with no small business set-aside applied. The maintenance agreement supports BD flow cytometry instrumentation operated by the Institute, consistent with BD Biosciences' established supplier...
- The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded Becton, Dickinson and Company BD Biosciences, Systems and Reagents Division a $13,713.30 firm fixed price purchase order for bridge maintenance agreement services. BD Biosciences will perform the services in Bethesda, Maryland over a period of four months concluding in December 2023. As the prime contractor, BD Biosciences specializes in providing research reagents and instruments that...
- Becton, Dickinson and Company (BD), through its BDB Division operating as BD Biosciences, was awarded a Firm Fixed Price contract by the National Cancer Institute (NCI) on May 3, 2017, with a ceiling value of $17,928.00. This contract was executed as a Blanket Purchase Agreement (BPA) call without small business set-aside designation, reflecting BD's competitive standing as a large, established medical technology manufacturer. The work was to be performed in Bethesda, Maryland, with an...